Details
| Stereochemistry | MIXED |
| Molecular Formula | C16H24N2 |
| Molecular Weight | 244.3752 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C(CC(C)N(C)C)(C#N)C1=CC=CC=C1
InChI
InChIKey=WFLSCFISQHLEED-UHFFFAOYSA-N
InChI=1S/C16H24N2/c1-13(2)16(12-17,11-14(3)18(4)5)15-9-7-6-8-10-15/h6-10,13-14H,11H2,1-5H3
| Molecular Formula | C16H24N2 |
| Molecular Weight | 244.3752 |
| Charge | 0 |
| Count |
|
| Stereochemistry | MIXED |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: http://home.intekom.com/pharm/hmr/peraconx.html
Sources: http://home.intekom.com/pharm/hmr/peraconx.html
Isoaminile is a cough suppressant that acts by influencing the cough centre.
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
40 mg 3 times / day multiple, oral Studied dose Dose: 40 mg, 3 times / day Route: oral Route: multiple Dose: 40 mg, 3 times / day Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: unknown Food Status: UNKNOWN Sources: |
|
750 mg single, intravenous Overdose Dose: 750 mg Route: intravenous Route: single Dose: 750 mg Sources: |
healthy |
Other AEs: Nystagmus... |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Nystagmus | 1 pt | 750 mg single, intravenous Overdose Dose: 750 mg Route: intravenous Route: single Dose: 750 mg Sources: |
healthy |
PubMed
| Title | Date | PubMed |
|---|---|---|
| A comparative randomized double-blind clinical trial of isoaminile citrate and chlophedianol hydrochloride as antitussive agents. | 1982-08 |
|
| [Goodpasture's syndrome--rapid remission after early plasmapheresis and high-dose cyclophosphamide therapy (author's transl)]. | 1982-06-15 |
|
| Some cases of acute intoxications from compulsive use of isoaminile. | 1979-09 |
|
| [Drug abuse of isoaminile]. | 1973-04-30 |
|
| Isoaminile as inhibitor of muscarinic and nicotinic ganglionic receptors. | 1970 |
|
| Isoaminile citrate as a cough suppressant. | 1966-03 |
|
| [ON THE MORPHINE-LIKE PROPERTIES OF A NEW ANTITUSSIVE (ISOAMINIL; PERACON, MULLATUSS)]. | 1964-10 |
|
| Evaluation of isoaminile citrate as an antitussive. | 1962-01-01 |
|
| [Further clinical experiences with peracon and peracon expectorant]. | 1961-11 |
|
| [2 Years of experience with peracon in general practice]. | 1960-05-05 |
|
| [Peracon in practice. Experiences with a new kind of antitussive agent]. | 1959-10-30 |
|
| [Clinical comparison of a new antitussive substance (peracon) with codeine & dicodide]. | 1959-05 |
|
| [Experiences with the cough medication peracon]. | 1958-09 |
Sample Use Guides
In Vivo Use Guide
Sources: http://home.intekom.com/pharm/hmr/peraconx.html
One to two medicine measurefuls (5 to 10 mL) three to four times daily.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:17:25 GMT 2025
by
admin
on
Mon Mar 31 18:17:25 GMT 2025
|
| Record UNII |
R4823W2PQL
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QR05DB04
Created by
admin on Mon Mar 31 18:17:25 GMT 2025 , Edited by admin on Mon Mar 31 18:17:25 GMT 2025
|
||
|
WHO-ATC |
R05DB04
Created by
admin on Mon Mar 31 18:17:25 GMT 2025 , Edited by admin on Mon Mar 31 18:17:25 GMT 2025
|
||
|
NCI_THESAURUS |
C66917
Created by
admin on Mon Mar 31 18:17:25 GMT 2025 , Edited by admin on Mon Mar 31 18:17:25 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1076
Created by
admin on Mon Mar 31 18:17:25 GMT 2025 , Edited by admin on Mon Mar 31 18:17:25 GMT 2025
|
PRIMARY | |||
|
DTXSID5057830
Created by
admin on Mon Mar 31 18:17:25 GMT 2025 , Edited by admin on Mon Mar 31 18:17:25 GMT 2025
|
PRIMARY | |||
|
C011001
Created by
admin on Mon Mar 31 18:17:25 GMT 2025 , Edited by admin on Mon Mar 31 18:17:25 GMT 2025
|
PRIMARY | |||
|
SUB08310MIG
Created by
admin on Mon Mar 31 18:17:25 GMT 2025 , Edited by admin on Mon Mar 31 18:17:25 GMT 2025
|
PRIMARY | |||
|
201-033-5
Created by
admin on Mon Mar 31 18:17:25 GMT 2025 , Edited by admin on Mon Mar 31 18:17:25 GMT 2025
|
PRIMARY | |||
|
DB08944
Created by
admin on Mon Mar 31 18:17:25 GMT 2025 , Edited by admin on Mon Mar 31 18:17:25 GMT 2025
|
PRIMARY | |||
|
100000083362
Created by
admin on Mon Mar 31 18:17:25 GMT 2025 , Edited by admin on Mon Mar 31 18:17:25 GMT 2025
|
PRIMARY | |||
|
m6425
Created by
admin on Mon Mar 31 18:17:25 GMT 2025 , Edited by admin on Mon Mar 31 18:17:25 GMT 2025
|
PRIMARY | Merck Index | ||
|
6481
Created by
admin on Mon Mar 31 18:17:25 GMT 2025 , Edited by admin on Mon Mar 31 18:17:25 GMT 2025
|
PRIMARY | |||
|
R4823W2PQL
Created by
admin on Mon Mar 31 18:17:25 GMT 2025 , Edited by admin on Mon Mar 31 18:17:25 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105002
Created by
admin on Mon Mar 31 18:17:25 GMT 2025 , Edited by admin on Mon Mar 31 18:17:25 GMT 2025
|
PRIMARY | |||
|
2C-B-AN
Created by
admin on Mon Mar 31 18:17:25 GMT 2025 , Edited by admin on Mon Mar 31 18:17:25 GMT 2025
|
PRIMARY | It is thought to be a pro-drug for 2C-B described in Daniel Trachsels book "Phenethylamine : Von der Struktur zur Funktion"; the normal dose should be somewhere between 50-100mg. | ||
|
ISOAMINILE
Created by
admin on Mon Mar 31 18:17:25 GMT 2025 , Edited by admin on Mon Mar 31 18:17:25 GMT 2025
|
PRIMARY | |||
|
77-51-0
Created by
admin on Mon Mar 31 18:17:25 GMT 2025 , Edited by admin on Mon Mar 31 18:17:25 GMT 2025
|
PRIMARY | |||
|
27866
Created by
admin on Mon Mar 31 18:17:25 GMT 2025 , Edited by admin on Mon Mar 31 18:17:25 GMT 2025
|
PRIMARY | RxNorm | ||
|
C83839
Created by
admin on Mon Mar 31 18:17:25 GMT 2025 , Edited by admin on Mon Mar 31 18:17:25 GMT 2025
|
PRIMARY | |||
|
1487
Created by
admin on Mon Mar 31 18:17:25 GMT 2025 , Edited by admin on Mon Mar 31 18:17:25 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |